Ιατρική Σχολή
ΕΠΙΣΚΕΠΤΗΣ ΚΑΘΗΓΗΤΗΣ
|
Ακαδημαϊκός Τίτλος |
Έτος |
Ίδρυμα |
Τμήμα |
Τίτλος Διατριβής (Καταχωρείται προαιρετικά) |
|
PhD |
2010 |
National and Kapodistrian University of Athens, Greece |
Medicine |
Diastolic dysfunction estimation in hypertensive patients with TDI: Correlations with great artery stiffness and BNP plasma levels |
|
Medical Degree |
1999 |
National and Kapodistrian University of Athens, Greece |
Medicine |
|
|
Post Graduate Certificate |
2009 |
Institute for Therapy Advancement (ITA), Paris, France |
Interventional Cardiology |
|
|
Period of employment |
Employer |
Location |
Position |
|
|
From |
To |
|||
|
9/2018 |
4/2022 |
European University Cyprus |
Nicosia, Cyprus |
Scientific Collaborator |
|
10/2002 |
10/2009 |
Hypertension Unit, 1st Cardiology Clinic, NKUA |
Athens, Greece |
Scientific Collaborator |
|
Year |
Title |
Other authors |
Journal and Publisher / |
Vol. |
Pages |
|
2022 |
Role of diabetes in stroke: Recent advances in pathophysiology and clinical management |
Sian A Bradley, Kevin J Spring, Roy G Beran, Dimitrios Chatzis, Murray C Killingsworth, Sonu M M Bhaskar |
Diabetes Metab Res Rev . |
38(2) |
e3495 |
|
2021 |
Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes |
Dimitrios G Chatzis, Konstantinos Kolokathis, Kalliopi Magounaki, Stefanos Chatzidakis , Konstantinos Avramidis, Marianna Leopoulou, Theodoros P Angelopoulos, John Doupis |
Touch REV Endocrinol |
7(2) |
92-101. |
|
2021 |
Critical emergency medicine and the resuscitative care unit |
Mermiri M, Mavrovounis G, Chatzis D, Mpoutsikos I, Tsaroucha A, Dova M, Angelopoulou Z, Ragias D, Chalkias A, Pantazopoulos I |
Acute Crit Care |
36(1) |
22-28 |
|
2020 |
Peripherally Inserted Central Catheter lines for Intensive Care Unit and onco-hematologic patients: A systematic review and meta-analysis |
Mavrovounis G, Mermiri M, Chatzis DG, Pantazopoulos I |
Heart Lung |
49(6) |
922-933 |
|
2020 |
COVID-19 pandemic and cardiovascular disease: where do we stand?
|
Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP |
Minerva Cardioangiol. |
68(4) |
347-358 |
|
Date |
Topic |
International / Local |
Location* |
Role in Exhibition |
|
2022 |
Management of hypertension in the old and very elderly patients |
6th School of Hypertension |
Athens, GR |
Instructor |
|
2021 |
Management of patients with heart failure and renal failure |
Panhellenic congress of cardiometabolic risk factors, obesity and diabetes |
Lefkas, GR |
Invited speaker |
|
2021 |
Management of hypertension in the elderly population |
5th School of Hypertension |
Athens, GR |
Instructor |
|
2020 |
How to treat Atrial Fibrillation |
2020 MEETING OF THE WORKING GROUP ON OBESITY, DIABETES AND THE HIGH RISK PATIENT, EUROPEAN SOCIETY OF HYPERTENSION |
Chalkidiki, GR |
Moderator |
|
2018 |
Anticoagulant therapy in high risk patients with atrial fibrillation |
2020 MEETING OF THE WORKING GROUP ON OBESITY, DIABETES AND THE HIGH RISK PATIENT, EUROPEAN SOCIETY OF HYPERTENSION |
Chalkidiki, GR |
Invited speaker |
|
Date |
Title |
Funded by |
Project Role* |
|
2016 |
PAVE – AF (Pattern of Antithrombotic therapy in Very Elderly patients with Atrial Fibrillation) non – interventional multicenter Greek study. |
Pfizer Ltd |
Lead Clinician |
|
2014 |
TIGREECE multicenter national trial regarding the long term outcomes of Greek patients one year after myocardial infarction |
Astra Zeneca Ltd |
Principal Investigator |
|
2022 |
DEFINE - AF (DEtection of atrial FIbrillatioN in Elderly hypertensive pAtients with leFt atrial enlargement in Greece) |
Pfizer Ltd |
Principal Investigator and Private practice cardiologists’ coordinator |
|
2010 |
VALENTINES TRIAL (multicenter international trial regarding the effectiveness of the drug – eluting balloon Dior in the treatment of in stent restenosis |
EuroCor |
Research Team member |
|
2008 |
ROCKET AF (Rivaroxaban Once daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation |
Bayer Ltd |
Research Team member |
|
Period |
Organization |
Title of Position or Service |
|
11/2016 – 01/2019 |
Pfizer Ltd |
Senior Medical Advisor |
|
Date |
Title |
Awarded by: |
|
2015 |
Clinical Hypertension Specialist |
European Society of Hypertension |
|
2015 |
Full registration with license to practice in the specialist doctors list |
General Medical Council (GMC), U.K. |
|
2022 |
Referee, ESH congress 2022, Athens, GR |
European Society of Hypertension |